XML 67 R7.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidated Statements of Equity - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Noncontrolling Interest [Member]
Total
Balance (in shares) at Dec. 31, 2016 15,162,938          
Balance at Dec. 31, 2016 $ 152 $ 211,457 $ 391,934 $ 66,068 $ 0 $ 669,611
Net income attributable to National HealthCare Corporation 0 0 56,205 0 0 56,205
Net loss attributable to noncontrolling interest 0 0 0 0 (523) (523)
Equity contributed by noncontrolling interest 0 0 0 0 1,217 1,217
Other comprehensive income (loss) 0 0 0 1,436 0 1,436
Stock–based compensation $ 0 1,678 0 0 0 $ 1,678
Shares sold – options exercised (in shares) 49,195         48,995
Shares sold – options exercised $ 0 2,524 0 0 0 $ 2,524
Dividends declared to common stockholders $ 0 0 (28,716) 0 0 (28,716)
Balance (in shares) at Dec. 31, 2017 15,212,133          
Balance at Dec. 31, 2017 $ 152 215,659 419,423 67,504 694 703,432
Net income attributable to National HealthCare Corporation 0 0 58,964 0 0 58,964
Net loss attributable to noncontrolling interest 0 0 0 0 (265) (265)
Equity contributed by noncontrolling interest 0 0 0 0 750 750
Other comprehensive income (loss) 0 0 0 (2,048) 0 (2,048)
Stock–based compensation $ 0 1,778 0 0 0 $ 1,778
Shares sold – options exercised (in shares) 57,375         68,291
Shares sold – options exercised $ 1 2,865 0 0 0 $ 2,866
Dividends declared to common stockholders 0 0 (30,153) 0 0 (30,153)
Reclassification due to new accounting standards at Dec. 31, 2017 $ 0 0 68,201 (68,201) 0 0
Repurchase of common shares (in shares) (14,506)          
Repurchase of common shares $ 0 (867) 0 0 0 (867)
Balance (in shares) at Dec. 31, 2018 15,255,002          
Balance at Dec. 31, 2018 $ 153 219,435 516,435 (2,745) 1,179 734,457
Net income attributable to National HealthCare Corporation 0 0 68,211 0 0 68,211
Net loss attributable to noncontrolling interest 0 0 0 0 (235) (235)
Other comprehensive income (loss) 0 0 0 5,305 0 5,305
Stock–based compensation $ 0 1,878 0 0 0 $ 1,878
Shares sold – options exercised (in shares) 87,600         346,168
Shares sold – options exercised $ 0 2,346 0 0 0 $ 2,346
Dividends declared to common stockholders $ 0 0 (31,553) 0 0 (31,553)
Repurchase of common shares (in shares) (10,396)          
Repurchase of common shares $ 0 (872) 0 0 0 (872)
Distributions attributable to noncontrolling interest $ 0 0 0 0 (468) (468)
Balance (in shares) at Dec. 31, 2019 15,332,206          
Balance at Dec. 31, 2019 $ 153 $ 222,787 $ 553,093 $ 2,560 $ 476 $ 779,069